New imaging agent could reveal tumor oxygen, guiding better cancer care
NCT ID NCT03168737
First seen Nov 01, 2025 · Last updated May 23, 2026 · Updated 31 times
Summary
This early-phase trial studies how well a special PET-CT scan using a tracer called [18F]FAZA can measure oxygen levels in solid tumors. About 25 adults with breast, colorectal, pancreatic, or other solid tumors will receive the tracer and undergo imaging to see if the scan is reliable. The goal is to help doctors plan more effective treatments by understanding tumor hypoxia.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MALIGNANT SOLID NEOPLASM are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
M D Anderson Cancer Center
Houston, Texas, 77030, United States
Conditions
Explore the condition pages connected to this study.